Jonathan S. Edwards, Director at Phathom Pharmaceuticals, Inc. (PHAT), bought 2,067,861 shares at $19.00 ($35.4M) on 2019-10-29, disclosed to the SEC on 2019-10-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.20 | 23,558 | $358K | 1.0% |
| 2 | $15.20 | 991,672 | $15.1M | 42.5% |
| 3 | $19.00 | 24,426 | $464K | 1.3% |
| 4 | $19.00 | 1,028,205 | $19.5M | 55.1% |
| Total | $17.13 avg | 2,067,861 | $35.4M | 100% |